These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 26548356)

  • 1. The role of lymphocytes in the development and treatment of alopecia areata.
    Guo H; Cheng Y; Shapiro J; McElwee K
    Expert Rev Clin Immunol; 2015; 11(12):1335-51. PubMed ID: 26548356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
    Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
    Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial restoration of hair growth in the DEBR model for Alopecia areata after in vivo depletion of CD4+ T cells.
    McElwee KJ; Spiers EM; Oliver RF
    Br J Dermatol; 1999 Mar; 140(3):432-7. PubMed ID: 10233262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
    Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
    J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alopecia areata: autoimmunity--the evidence is compelling.
    Kalish RS; Gilhar A
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):164-7. PubMed ID: 14582666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T-cells in alopecia areata.
    Speiser JJ; Mondo D; Mehta V; Marcial SA; Kini A; Hutchens KA
    J Cutan Pathol; 2019 Sep; 46(9):653-658. PubMed ID: 30989699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward the Clonotype Analysis of Alopecia Areata-Specific, Intralesional Human CD8+ T Lymphocytes.
    Bertolini M; Uchida Y; Paus R
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):9-12. PubMed ID: 26551936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontiers in alopecia areata pathobiology research.
    Gilhar A; Laufer-Britva R; Keren A; Paus R
    J Allergy Clin Immunol; 2019 Dec; 144(6):1478-1489. PubMed ID: 31606262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?
    Paus R; Slominski A; Czarnetzki BM
    Yale J Biol Med; 1993; 66(6):541-54. PubMed ID: 7716973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesional infiltration of mast cells, Langerhans cells, T cells and local cytokine profiles in alopecia areata.
    Zhang X; Zhao Y; Ye Y; Li S; Qi S; Yang Y; Cao H; Yang J; Zhang X
    Arch Dermatol Res; 2015 May; 307(4):319-31. PubMed ID: 25638328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
    Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
    Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice.
    Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
    Arch Dermatol; 2002 Jul; 138(7):916-22. PubMed ID: 12071819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
    Gao Z; Jin YQ; Wu W
    Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice.
    Gilhar A; Shalaginov R; Assy B; Serafimovich S; Kalish RS
    J Investig Dermatol Symp Proc; 1999 Dec; 4(3):207-10. PubMed ID: 10674367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseases.
    Garzorz N; Alsisi M; Todorova A; Atenhan A; Thomas J; Lauffer F; Ring J; Schmidt-Weber C; Biedermann T; Eyerich S; Eyerich K
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2429-35. PubMed ID: 26416203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of hair follicle immune privilege collapse in alopecia areata: status and perspectives.
    Paus R; Bertolini M
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S25-7. PubMed ID: 24326544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model.
    McElwee KJ; Freyschmidt-Paul P; Hoffmann R; Kissling S; Hummel S; Vitacolonna M; Zöller M
    J Invest Dermatol; 2005 May; 124(5):947-57. PubMed ID: 15854035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alopecia areata. Clinical aspects, pathogenesis and rational therapy of a T-cell-induced autoimmune disease].
    Freyschmidt-Paul P; Happle R; Hoffmann R
    Hautarzt; 2003 Aug; 54(8):713-22. PubMed ID: 12942185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.